Latest News

Modern Oral sales nearly doubled while marketing spend squeezed profits.

It's a smart move to buy Micron's shares after their recent pullback.

A new NASA contract could be worth $10 billion -- or $15 billion -- to Voyager Technologies (and others).

Affirm and DraftKings posted strong Nov. 5, 2026 earnings growth but faced stock declines on mixed guidance, prompting a look at the Vanguard Mid-Cap ETF as a lower-risk alternative.

Reimbursed treatments are steadily displacing discounted programs.

Fiber coverage hits 50% of its footprint as hyperscaler demand accelerates.

Management outlines interim analysis timing and new survival data plans.

The rule boils down to two tests. Would the stock still pass them at today's price?

The IPO might now value the business at around $1.5 trillion or lower.

AI-related stocks rallied, and Elon Musk's Terafab has high ambitions.

Nvidia's business is still booming, but the investigation tied to its CEO adds a risk that no one can yet price in. Here are the four things to watch next week.

A delayed multiyear deal and memory market pressure tested an otherwise strong quarter.

Quality equity outflows weighed, but fixed income and ETFs kept momentum.

CoreWeave and Nebius have sold off hard, and this week's earnings could show how much the midterm results and higher borrowing costs are weighing on their growth plans.

A $1 million nest egg may seem generous, but on an annual basis, it could leave you short of your goals.

Most retirees fall short of the national average, but beating it doesn't guarantee retirement security.

Major indexes fell hard last week, but history has promising news for investors.

Walmart trades at more than 45 times earnings, while Target trades at 17. Here's why the valuation gap isn't as simple as it looks.

Sable Offshore (NYSE:SOC) is pursuing a bulk crude sale and other financing options to address a fourth-quarter cash shortfall after disruptions to sales from its Santa Ynez Unit, executives said on the company’s third-quarter 2026 earnings call. Chairman and Chief Executive Officer Jim Flores said

GSK (NYSE:GSK) is advancing a portfolio of long-acting medicines and combination treatments for respiratory and inflammatory diseases, with a particular focus on chronic obstructive pulmonary disease, a senior research executive said at Guggenheim’s Healthcare Innovation Conference. Kaivan Khavandi

Select Water Solutions (NYSE:WTTR) reported record adjusted EBITDA in the third quarter of 2026 as higher produced water volumes drove growth in its Water Infrastructure business. Executives said the recently completed acquisition of Pilot Water Solutions will contribute to fourth-quarter results an

Marti Technologies (NYSEAMERICAN:MRT) reported record third-quarter revenue and its first positive income from operations, as growth in ride-hailing trips and platform monetization outpaced increases in costs. The Türkiye-based mobility company said revenue rose 128% from a year earlier to $24.7 mi

KKR & Co. Inc. (NYSE:KKR) reported record third-quarter 2026 results across its three headline earnings measures, as management pointed to investment realizations, fundraising and a rebound in insurance activity. Adjusted net income was nearly $1.6 billion, or $1.78 per share, up 26% from a yea

NRG Energy (NYSE:NRG) plans to sell six power generation facilities to LS Power for $4 billion and increase its planned share repurchases, as the company reported higher third-quarter earnings and introduced its 2027 financial outlook. The assets being sold have a combined capacity of just under 4.

Somnigroup International (NYSE:SGI) reported record third-quarter 2026 sales and adjusted earnings, but said results fell short of its expectations as a technology rollout disrupted its Dreams business and the global bedding market remained weak. The company posted net sales of $2.4 billion, adjust